Association Between MitoScore, BMI, and Body Fat Percentage as a Predictive Marker for the Outcome of In-Vitro Fertilization (IVF).

assisted reproductive technique body fat body mass index fertility mitoscore

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 05 04 2022
accepted: 27 07 2022
entrez: 1 9 2022
pubmed: 2 9 2022
medline: 2 9 2022
Statut: epublish

Résumé

Background Infertility is defined as the inability to establish a pregnancy within 12 months of regular and unprotected sexual intercourse. In response to these problems, assisted reproductive techniques (ARTs) have made profound impacts on the therapeutic management of infertility. However, in-vitro fertilization (IVF) success rates are confounded by several internal and external factors. A relatively new approach to embryo assessment is known as MitoScore (Igenomix, Miami, USA). As a result, we sough to evaluate whether MitoScore can help in predicting in IVF outcomes, and to assess the relationship between MitoScore, BMI, and body fat percentage in determining the success of ARTs. Methods Using retrospective cohort, a study population consisting of 166 women aged 26-43 who were undergoing ART with pre-implantation genetic testing for aneuploidy (PGT-A) was assessed to determine if MitoScore, BMI, and body fat percentage impacted IVF outcomes. Results MitoScore, BMI, and body fat percentage were significantly lower in pregnant women as compared to non-pregnant women. Furthermore, MitoScore was correlated with subclasses of IVF outcomes (delivery, biochemical pregnancy, and spontaneous abortion) and was found to be positively correlated with BMI in patients with biochemical pregnancies. Conclusion Our findings suggest that MitoScore, BMI, and body fat percentage could act as critical parameters in determining the success of ART. However, the association between MitoScore, BMI, and body fat percentage does not appear to be a significant confounding factor to determine pregnancy outcome at this stage. Still, many factors need to be considered to establish the correlation reliably.

Identifiants

pubmed: 36046274
doi: 10.7759/cureus.27367
pmc: PMC9418516
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e27367

Informations de copyright

Copyright © 2022, Arora et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Genet. 2015 Jun 03;11(6):e1005241
pubmed: 26039092
Case Rep Genet. 2017;2017:4397434
pubmed: 28928993
Hum Reprod. 2016 Dec;31(12):2772-2780
pubmed: 27664215
Gynecol Endocrinol. 2011 Nov;27(11):880-4
pubmed: 21500991
Reprod Biomed Online. 2011 Oct;23(4):421-39
pubmed: 21885344
BMC Med. 2019 Jun 26;17(1):114
pubmed: 31238940
J Assist Reprod Genet. 2017 Dec;34(12):1581-1585
pubmed: 29080967
Fertil Steril. 2017 Jan;107(1):34-42.e3
pubmed: 27793366
Clin Biochem. 2018 Dec;62:2-10
pubmed: 29555319
Obstet Gynecol. 2011 Jul;118(1):63-70
pubmed: 21691164
Fertil Steril. 2015 Sep;104(3):534-41.e1
pubmed: 26051102
Hum Reprod. 2017 Apr 1;32(4):954-962
pubmed: 28333210
PLoS One. 2020 Jan 13;15(1):e0227619
pubmed: 31929583
J Assist Reprod Genet. 2018 Nov;35(11):2013-2023
pubmed: 30132171
Fertil Steril. 2013 Mar 15;99(4):1044-8
pubmed: 23394777
Fertil Steril. 2015 Feb;103(2):402-13.e11
pubmed: 25516078
Reproduction. 2019 Jun;157(6):R235-R242
pubmed: 30844752
Reprod Biol Endocrinol. 2015 Apr 26;13:37
pubmed: 25928197
Biol Reprod. 2010 Jul;83(1):52-62
pubmed: 20130269
Hum Reprod Update. 2010 Nov-Dec;16(6):577-89
pubmed: 20581128
Fertil Steril. 2009 Jun;91(6):2281-94
pubmed: 19481642
Semin Perinatol. 2017 Oct;41(6):345-353
pubmed: 28818301
Hum Reprod Update. 2019 Jul 1;25(4):439-451
pubmed: 30941397
J Obstet Gynaecol. 2005 Oct;25(7):689-93
pubmed: 16263545
Biomed Res Int. 2014;2014:517125
pubmed: 24877108
Hum Reprod. 2005 Mar;20(3):593-7
pubmed: 15608038
Reprod Sci. 2019 Mar;26(3):404-411
pubmed: 29779472
J Turk Ger Gynecol Assoc. 2016 Jan 12;17(2):83-90
pubmed: 27403074
Fertil Steril. 2018 Dec;110(7):1311-1317
pubmed: 30503130
J Assist Reprod Genet. 2018 May;35(5):871-877
pubmed: 29508122

Auteurs

Himanshu Arora (H)

Urology, University of Miami, Miami, USA.

Ineabelle Collazo (I)

South Florida Institute for Reproductive Medicine, IVFMD, Miami, USA.

Juergen Eisermann (J)

South Florida Institute for Reproductive Medicine, IVFMD, Miami, USA.
Obstetrics and Gynecology, University of Miami, Miami, USA.

Nicholas Hendon (N)

South Florida Institute for Reproductive Medicine, IVFMD, Miami, USA.

Manish Kuchakulla (M)

Urology, Weill Cornell Medical Center, New York, USA.

Kajal Khodamoradi (K)

Urology, University of Miami, Miami, USA.

Joginder Bidhan (J)

Urology, University of Miami, Miami, USA.

Alexandra Dullea (A)

Urology, University of Miami, Miami, USA.

Isaac Zucker (I)

Urology, Florida International University, Miami, USA.

Zahra Khosravizadeh (Z)

Anatomy, Tehran University of Medical Sciences, Tehran, IRN.

Parth Shah (P)

Medicine, American University of Antigua, Osbourn, ATG.

Maria Bustillo (M)

South Florida Institute for Reproductive Medicine, IVFMD, Miami, USA.
Obstetrics and Gynecology, University of Miami, Miami, USA.

Classifications MeSH